New dialysis method aims to trap toxic iron in critically ill patients
NCT ID NCT07236463
Summary
This study is testing if adding a drug called MEX-CD1 to dialysis fluid can safely remove excess iron from the blood of ICU patients with severe kidney failure caused by sepsis. Fourteen participants will receive two 24-hour dialysis sessions—one standard and one with the added drug—to compare how much iron is removed. The goal is to see if reducing iron levels might help protect organs and improve recovery in these critically ill patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nimes University Hospital
Nîmes, Gard, 30000, France
Conditions
Explore the condition pages connected to this study.